CMS Seeks List Of "Authorized" Generics For Use In "Best Price" Reporting, GPhA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The Generic Pharmaceutical Association anticipates the National Governors Association's updated Medicaid recommendations will endorse the inclusion of authorized generics in Medicaid "best price" reporting. CMS has indicated it will consider adding authorized generics to its calculations.